SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001654954-19-009573
Filing Date
2019-08-14
Accepted
2019-08-14 16:10:35
Documents
6
Period of Report
2019-06-07
Items
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 AMENDED CURRENT REPORT edsa_8ka.htm 8-K/A 50478
2 CONSENTS OF EXPERTS AND COUNSEL edsa_ex231.htm EX-23.1 4287
3 AUDITED FINANCIAL STATEMENTS FOR THE YEARS ENDED DECEMBER 31, 2018 AND 2017 edsa_ex992.htm EX-99.2 770948
4 UNAUDITED CONDENSED INTERIM FINANCIAL STATEMENTS FOR THE THREE MONTHS ENDED MARC edsa_ex993.htm EX-99.3 553153
5 UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL STATEMENTS FOR THE THREE MONTHS edsa_ex995.htm EX-99.5 279190
6 IMAGE edsa_ex993000.jpg GRAPHIC 674
  Complete submission text file 0001654954-19-009573.txt   1660251
Mailing Address 100 SPY COURT MARKHAM A6 L3R 5H6
Business Address 100 SPY COURT MARKHAM A6 L3R 5H6 (905) 475-1234
Edesa Biotech, Inc. (Filer) CIK: 0001540159 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0930
Type: 8-K/A | Act: 34 | File No.: 001-37619 | Film No.: 191026438
SIC: 2834 Pharmaceutical Preparations